Dendritic cells (DCs) are professional antigen-presenting cells that play a crucial role in activating naive T cells through presenting antigen information, thereby influencing immunity and anti-cancer responses. Fascin, a 55-kDa actin-bundling protein, is highly expressed in mature DCs and serves as a marker protein for their identification. However, the precise role of fascin in intratumoral DCs remains poorly understood. In this review, we aim to summarize the role of fascin in both normal and intratumoral DCs. In normal DCs, fascin promotes immune effects through facilitating DC maturation and migration. Through targeting intratumoral DCs, fascin inhibitors enhance anti-tumor immune activity. These roles of fascin in different DC populations offer valuable insights for future research in immunotherapy and strategies aimed at improving cancer treatments.
Ginkgo biloba is generally considered as safe herbal extract in clinical application. Ginkgo Folium is a living fossil plant, which has been used in record by over few thousands of years. The extract of G. biloba, has been used extensively for the treatment of diseases related to the central nervous system and psychiatric disorders. Recently, different lines of evidence indicated that G. biloba exhibited anti-cancer effects. The potential therapeutic effect may due to antioxidant, anti-angiogenic and gene regulatory actions. In addition, Ginkgo Folium was studied in pharmacodynamic interactions induced by herb-drug interactions. These studies indicated that G. biloba usually exhibits synergistic effect. The extracts derived from G. biloba exhibits promising anticancer effect, including flavonoids, ginkgolide, and phenolic acids etc. This chapter will discuss the anticancer effect and mechanism of extracts derived from various parts of G. biloba, the possible usage as an adjuvant therapy in cancer treatment, and the development of G. biloba as potential novel anticancer drugs.